Skip to main content
2026 AANS Annual Scientific Meeting Main banner

    Aierpati Maimaiti, MD, PhD

    Neurosurgeon
    Xinjiang Medical University Affiliated the First Hospital

    Aierpati Maimaiti, MD, is a PhD Candidate in Neurosurgery at Xinjiang Medical University and a Guest PhD Candidate at the Faculty of Health, Medicine and Life Sciences, Maastricht University . He holds a National Practicing Physician License (China) and completed his Standardized Medical Residency Training (Neurosurgery) at The First Affiliated Hospital of Xinjiang Medical University from 2019 to 2022.Dr. Aierpati Maimaiti’s research focuses on the application of artificial intelligence and multi-omics in the diagnosis and treatment of intracranial aneurysms and gliomas. He has published 44 SCI-indexed papers, serving as the first, co-first, or corresponding author on 30 of these publications, with a current H-Index of 11. His study on DNA methylation regulator-mediated modification patterns was recognized by Clarivate Analytics ESI as a "Highly Cited Paper" (Top 1%) and "Hot Paper" (Top 0.1%) in Clinical Medicine.
    His current work involves several funded projects, including the "Genome Association Study and AI-based Clinical Precision Diagnosis and Treatment Model Development for Neurosurgical disease" and the "Construction of a Shared Database Platform for Neurosurgical Specialties Based on Artificial Intelligence". Additionally, he investigates molecular mechanisms in gliomas, utilizing CRISPR-Cas9 screening and analyzing LncRNA regulation of signaling pathways. He has also contributed to the development and validation of deep learning models for predicting intracranial aneurysm rupture risk.
    Dr. Aierpati Maimaiti has been awarded the National Scholarship for Doctoral Students by the Ministry of Education of China for two consecutive academic years (2023-2025). Internationally, he has received Merit Travel Grants from the European Society for Medical Oncology (ESMO) and the Molecular Analysis for Precision Oncology (MAP) Congress, as well as the Best Poster Award from the Cancer Cachexia Society in 2025. He serves as a reviewer for multiple journals, including Frontiers in Immunology, Journal of translational Medicine.

    Disclosure(s): No financial relationships to disclose

    Presentation(s):